Sector: Health Care
Director information for IOVANCE BIOTHERAPEUTICS INC
Board as disclosed in the proxy statement filed April 28, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Athena Countouriotis, M.D. | Director | 54 | [] | [] | 2026 |
| Frederick G. Vogt, Ph.D., J.D. | Interim Chief Executive Officer and President, General Counsel; Director | 52 | [] | [] | 2026 |
| Friedrich Graf Finckenstein, M.D. | Chief Medical Officer | 59 | [] | [] | 2026 |
| Iain Dukes, D. Phil. | Chairman of the Board of Directors | 67 | [] | [] | 2026 |
| Michael Weiser, M.D., Ph.D. | Director | 63 | [] | [] | 2026 |
| Raj K. Puri, M.D., Ph.D. | Chief Regulatory Officer | 70 | [] | [] | 2026 |
| Ryan Maynard | Director | 56 | [] | [] | 2026 |
| Wayne P. Rothbaum | Director | 58 | [] | [] | 2026 |
| Wendy Yarno | Director | 71 | [] | [] | 2026 |
